Download the eBook

Thank you for filling out the form!

The document will be sent to your email and you can review it at your own time, at any time.

Download
FdKkybztNvvWmgWexXocTT

Medical device development is complex, expensive, and time-consuming. 3D printing is changing the industry by making prototyping faster, reducing costs, and improving product validation.

This guide will walk you through how leading manufacturers leverage 3D printing to streamline workflows and stay ahead. Designed for professionals like you, it offers innovative solutions to enhance efficiency and drive success.

What you’ll Learn?

  • Save Costs: Reduce cost efficiency by reducing prototyping expenses and production costs.
  • Accelerate Time to Market: Accelerate design and prototyping, getting products to market faster with quicker validation.
  • Optimize Product Design: Prototype more efficiently, gather feedback early, and iterate rapidly for improved designs.
  • Minimize Risk: Reduce errors, enhance validation, and ensure more reliable products.
  • Gain Expert Insights: Learn from industry leaders and discover best practices that will improve your manufacturing processes.
  • Success Stories: Explore success stories where Stratasys technology has directly improved patient care and advanced medical device development.

Who Should Read This Guide?
Medical device manufacturers looking to lower costs, speed up development, and enhance product quality through advanced manufacturing solutions.

How Stratasys Customers Innovate their Medical Manufacturing

"On average, we estimate FDM parts cost 80% less to produce when compared to machined parts. Over a four-year period, we estimated a $6 million savings versus what would have been spent if we had contracted the parts to an outside machine shop."

“With just two weeks ahead of us...I designed the inhaler prototype and we 3D printed the parts... we wanted to show how small the device would be, how it would function, how the electronics would work, and how the airflow would work... this changed the whole conversation with the investor.”